Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

计划入组 8 人 · 首次发布于 2023 年 8 月 23 日

Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk

计划入组 63 人 · 首次发布于 2022 年 6 月 2 日

DKA Optic Ultrasound

计划入组 108 人 · 首次发布于 2014 年 5 月 5 日

DKAH-3-CL

MAdCAM Targeted DK4/10 (Deka Biosciences)

CD14 targeted DK4/10 (Deka Biosciences)

DNA International Hospital

Vietnam

DHA COFFEE COMPANY LIMITED

Vietnam

HYWEL DDA UNIVERSITY HEALTH BOARD

United Kingdom

Increased Risk of Diabetic Ketoacidosis with Sotagliflozin in Type 1 Diabetes Patients

FDA Panel Rejects Sotagliflozin for Type 1 Diabetes with Mild-to-Moderate CKD

FDA Panel Rejects Sotagliflozin for Type 1 Diabetes and CKD